India, March 4 -- Shares of Helius Medical Technologies, Inc. (HSDT) gained over 18% on Monday after the company said received HCPCS codes for the Portable Neuromodulation Stimulator (PoNS) mouthpiece and controller.
HSDT is currently trading at $5.41, up $0.85 or 18.57%, on the Nasdaq. The stock opened its trading at $6.66 after closing Friday at $4.56. The stock has traded between $4.29 and $16.00 in the past 52 weeks.
The company announced that the Centers for Medicare & Medicaid Services has assigned Healthcare Common Procedure Coding System (HCPCS) Level II codes A4593, "Neuromodulation stimulator system, adjunct to rehabilitation therapy regime" to describe the PoNS controller and A4594, "Neuromodulation stimulator system, adjunct t...